Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples

Overview

Journal Endocr Pathol

Specialties Endocrinology
Pathology

Date 2022 May 21

PMID 35596875

Authors

Uma Mohan

Sumsum P Sunny

Pramila Mendonca

Moni A Kuriakose

Subramanian Kannan

Amritha Suresh

Affiliations

Soon will be listed here.

Abstract

Conventional cytology-based diagnosis for thyroid cancer is limited with more than 30-45% of nodules categorized as indeterminate, necessitating surgery for confirming or refuting the diagnosis. This systematic review and meta-analysis were aimed at identifying immunocytochemical markers effective in delineating benign from malignant thyroid lesions in fine needle aspiration cytology (FNAC) samples, thereby improving the accuracy of cytology diagnosis. A systematic review of relevant articles (2000-2021) from online databases was carried out and the search protocol registered in PROSPERO database (CRD42021229121). The quality of studies was assessed using QUADAS-2. Review Manager 5.4.1 from Cochrane collaboration and MetaDisc Version 1.4 was used to conduct the meta-analysis. Bias in the studies were visually analyzed using funnel plots, and statistical significance was evaluated by Egger's test. Systematic review identified 64 original articles, while meta-analysis in eligible articles (n = 41) identified a panel of 5 markers, Galectin-3, HBME-1, CK-19, CD-56, and TPO. Assessment of the diagnostic performance revealed that Gal-3 (sensitivity: 0.81; CI: 0.79-0.83; specificity: 0.84; CI: 0.82-0.85) and HBME-1 (sensitivity: 0.83; Cl: 0.81-0.86; specificity: 0.85; CI: 0.83-0.86) showed high accuracy in delineating benign from malignant thyroid nodules. Efficacy analysis in indeterminate nodules showed Gal-3 and HBME-1 have high specificity of 0.86 (CI 0.84-0.89) and 0.82 (CI 0.78-0.86), respectively, and low sensitivity of 0.76 (CI 0.72-0.80) and 0.75 (CI 0.70-0.80), respectively. Diagnostic odds ratio (DOR) of Galectin-3 and HBME-1 were 39.18 (CI 23.38-65.65) and 24.44 (CI 11.16-53.54), respectively. Significant publication bias was observed for the markers Galectin-3 and CK-19 (p < 0.05). The panel of 5 markers identified from this meta-analysis are high-confidence candidates that need to be validated in thyroid cytology to establish their efficacy and enable clinical applicability.

Citing Articles

A case series of ultrasound and pathological assessment of follicular thyroid tumors: Addressing indeterminate malignancy.

Wang X, Zhou H, Iqbal M, Pan D, Zuo J, Moazzam N Medicine (Baltimore). 2025; 104(3):e41196.

PMID: 39836565 PMC: 11749504. DOI: 10.1097/MD.0000000000041196.

Management of Thyroid Nodules.

Uludag M, Unlu M, Kostek M, Aygun N, Caliskan O, Ozel A Sisli Etfal Hastan Tıp Bul. 2023; 57(3):287-304.

PMID: 37900341 PMC: 10600596. DOI: 10.14744/SEMB.2023.06992.

2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.

Durante C, Hegedus L, Czarniecka A, Paschke R, Russ G, Schmitt F Eur Thyroid J. 2023; 12(5).

PMID: 37358008 PMC: 10448590. DOI: 10.1530/ETJ-23-0067.

Immunocytochemistry Profile of Benign Thyroid Nodules Not Responding to Thermal Ablation: A Retrospective Study.

Bernardi S, Taccogna S, DAngelo M, Giudici F, Mauri G, Raggiunti B Int J Endocrinol. 2023; 2023:7951942.

PMID: 37082757 PMC: 10113047. DOI: 10.1155/2023/7951942.

References

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D, Pineros M . Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018; 144(8):1941-1953. DOI: 10.1002/ijc.31937. View

Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 26(1):1-133. PMC: 4739132. DOI: 10.1089/thy.2015.0020. View

Zhao C, Xu H, Xu J, Sun C, Chen W, Liu B . Risk stratification of thyroid nodules with Bethesda category III results on fine-needle aspiration cytology: The additional value of acoustic radiation force impulse elastography. Oncotarget. 2016; 8(1):1580-1592. PMC: 5352079. DOI: 10.18632/oncotarget.13685. View

Cibas E, Ali S . The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017; 27(11):1341-1346. DOI: 10.1089/thy.2017.0500. View

Armanious H, Adam B, Meunier D, Formenti K, Izevbaye I . Digital gene expression analysis might aid in the diagnosis of thyroid cancer. Curr Oncol. 2020; 27(2):e93-e99. PMC: 7253736. DOI: 10.3747/co.27.5533. View

Nair C, Babu M, Biswas L, Jacob P, Menon R, Revathy A . Lack of Association of B-type Raf Kinase V600E Mutation with High-risk Tumor Features and Adverse Outcome in Conventional and Follicular Variants of Papillary Thyroid Carcinoma. Indian J Endocrinol Metab. 2017; 21(2):329-333. PMC: 5367239. DOI: 10.4103/ijem.IJEM_353_16. View

Santos M, Buzolin A, Gama R, da Silva E, Dufloth R, Figueiredo D . Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides. Thyroid. 2018; 28(12):1618-1626. PMC: 6308280. DOI: 10.1089/thy.2018.0254. View

Gonzalez H, Martinez J, Vargas-Salas S, Solar A, Veliz L, Cruz F . A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study. Thyroid. 2017; 27(8):1058-1067. PMC: 5564024. DOI: 10.1089/thy.2017.0067. View

Nikiforov Y, Ohori N, Hodak S, Carty S, LeBeau S, Ferris R . Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011; 96(11):3390-7. PMC: 3205883. DOI: 10.1210/jc.2011-1469. View

10.

Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P . Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid. 2011; 21(10):1067-73. DOI: 10.1089/thy.2011.0014. View

11.

Collet J, Hurbain I, Prengel C, Utzmann O, Scetbon F, Bernaudin J . Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. Br J Cancer. 2005; 93(10):1175-81. PMC: 2361502. DOI: 10.1038/sj.bjc.6602822. View

12.

Whiting P, Rutjes A, Westwood M, Mallett S, Deeks J, Reitsma J . QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8):529-36. DOI: 10.7326/0003-4819-155-8-201110180-00009. View

13.

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

14.

Duval S, Tweedie R . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. DOI: 10.1111/j.0006-341x.2000.00455.x. View

15.

Aiad H, Kandil M, Asaad N, El-Kased A, El-Goday S . Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions. J Egypt Natl Canc Inst. 2009; 20(1):36-46. View

16.

Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A . Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol. 2002; 26(6):366-72. DOI: 10.1002/dc.10111. View

17.

Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R . Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol. 2008; 9(6):543-9. DOI: 10.1016/S1470-2045(08)70132-3. View

18.

Carpi A, Rossi G, Di Coscio G, Iervasi G, Nicolini A, Carpi F . Galectin-3 detection on large-needle aspiration biopsy improves preoperative selection of thyroid nodules: a prospective cohort study. Ann Med. 2009; 42(1):70-8. DOI: 10.3109/07853890903439778. View

19.

Ersoz S, Sert H, Yandi M, Erem C, Mungan S, Ersoz H . The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology. Pathol Oncol Res. 2008; 14(4):457-60. DOI: 10.1007/s12253-008-9041-0. View

20.

Kim M, Kim H, Hong S, Shong Y, Gong G . Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol. 2006; 50(1):28-34. DOI: 10.1159/000325891. View